Longitudinal assessment of cardiac function in infants with Down's syndrome using novel echocardiography techniques - project protocol.
Aisling SmithEleanor J MolloyJan MiletinAnna CurleyJoanne BalfeOrla FranklinAfif El-KhuffashPublished in: HRB open research (2020)
Background: Down's syndrome (DS) is the most common chromosomal abnormality globally. Ireland has one of the highest rates of DS in the western world with an incidence of 1:444 live births. Congenital heart disease (CHD) and pulmonary hypertension (PH) are the commonest morbidities affecting the cardiovascular system in DS. PH is associated with significant morbidity and an increase risk of mortality. The impact of the diagnosis of DS, the presence of CHD and the associated PH on myocardial function during transition and over the first 2 years of age in this population is not well defined and warrants further study. In particular, serial measurements of pulmonary pressures in this population over the first week of age are lacking. This study aims to characterise myocardial function and pulmonary haemodynamics in infants with Down syndrome during the transitional period (over the first week of age) and throughout the first two years of age. Methods: A prospective, observational study utilising novel echocardiography techniques to assess myocardial function and pulmonary haemodynamics over the first two years of age in infants with Down Syndrome. A population of healthy infants without CHD or a diagnosis of DS will be recruited as controls. This study will be conducted across the three Dublin maternity units. Discussion: In total, 70 babies with DS have been enrolled into this study with 292 echocardiograms performed to date. Further evaluation of cardiac performance in DS infants with and without CHD may yield more insight into the pathophysiology of cardiac dysfunction and pulmonary hypertension that are recognised features in these patients. This could aid in our ability to monitor and treat patients, as well as improve our ability to predict outcomes.
Keyphrases
- pulmonary hypertension
- left ventricular
- end stage renal disease
- congenital heart disease
- ejection fraction
- pulmonary artery
- randomized controlled trial
- peritoneal dialysis
- clinical trial
- heart failure
- chronic kidney disease
- newly diagnosed
- gene expression
- pulmonary arterial hypertension
- coronary artery
- oxidative stress
- coronary artery disease
- case report
- patient reported